Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126682) titled 'Adherence and Influencing Factors of CDK4/6 Inhibitors Plus Endocrine Therapy in Patients with HR+/HER2- Early Breast Cancer: A Real-World Retrospective Analysis' on June 13.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: Jilin University-China-Japan Friendship Hospital
Condition:
breast cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-14
Target Sample Size: Grouping based on the type of CDK4/6 inhibitors :136;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=323750
Published by HT Digit...